Pharmacologic Treatment of IBS

Content Type: presentation

Presenter: Lin Chang, MD, FACG

Presenter Disclosure: Advisory Committee/Board Member: Cairn Diagnostics, IM HealthScience, Synergy Consultant: Biomerica Grant/Research Support: Ardelyx Speakers Bureau: Allergan, Takeda

Event: 2018 ACG Postgraduate Course

Release Date: 6/16/2019

Expiration Date: 6/16/2022

Objective: Evaluate the selection of appropriate pharmacologic agents for the treatment of IBS.